Baxter International Inc (B1AX34)

B3


	Symbol		Exchange		Currency
	B1AX34		B3		BRL	Delayed
	BAX		NYSE		USD	Real-time
	BAX		Mexico		MXN	Delayed
	BAX		BIVA		MXN	Delayed
	1BAX		Milan		EUR	Real-time
	BAX		Frankfurt		EUR	Delayed
	BAX		TradeGate		EUR	Delayed
	BAX		Vienna		EUR	Real-time

Currency in BRL

Disclaimer

105.23

+7.00(+7.13%)

Closed09/10

Fair Value

Day's Range

105.23

105.23

52 wk Range

78.26

110.00

B1AX34 Income Statement

Featured here, the Income Statement (earnings report) for Baxter International Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

11,362

11,673

12,146

14,506

14,813

Total Revenues Growth

+2.37%

+2.74%

+4.05%

+19.43%

+2.12%

Cost Of Revenues

6,541

7,038

7,281

8,806

9,151

Gross Profit

4,821

4,635

4,865

5,700

5,662

Gross Profit Growth

+0.21%

-3.86%

+4.96%

+17.16%

-0.67%

Gross Profit Margin %

42.43%

39.71%

40.05%

39.29%

38.22%

Other Operating Expenses, Total

2,999

2,922

3,135

4,149

4,149

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.37%	-2.57%	+7.29%	+32.34%	0%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	561	519	530	599	655
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,442	2,405	2,605	3,550	3,495
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-4	-2	-	-	-1

Operating Income

1,822

1,713

1,730

1,551

1,513

Operating Income Growth

+1.17%

-5.98%

+0.99%

-10.35%

-2.45%

EBIT Margin %

16.04%

14.67%

14.24%

10.69%

10.21%

Net Interest Expenses

-71

-134

-145

-395

-442

Net Interest Expenses Growth

-57.78%

-88.73%

-8.21%

-172.41%

-11.9%

Interest Expense, Total

-111

-153

-159

-415

-512

Interest And Investment Income

40

19

14

20

70

Other Non Operating Expenses, Total

-30

-50

-19

7

-47

EBT, Excl. Unusual Items

1,721

1,529

1,566

1,163

1,024

Gain (Loss) On Sale Of Assets

-

-

-

-75

-

Other Unusual Items, Total

-618

-156

-87

-457

-529

EBT, Incl. Unusual Items

970

1,292

1,116

-2,650

-103

EBT, Incl. Unusual Items Growth

-40.01%

+33.2%

-13.62%

-337.46%

+96.11%

EBT, Incl. Unusual Items Margin

8.54%

11.07%

9.19%

-18.27%

-0.7%

Income Tax Expense

-41

182

83

4

-34

Net Income to Company

1,011

1,110

1,295

-2,421

2,663

Minority Interest

-10

-8

-11

-12

-7

Net Income

1,001

1,102

1,284

-2,433

2,656

Net Income Growth

-35.25%

+10.09%

+16.52%

-289.49%

+209.17%

Net Income Margin %

8.81%

9.44%

10.57%

-16.77%

17.93%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

1,001

1,102

1,022

-2,666

-76

Basic EPS - Continuing Operations

1.97

2.17

2.04

-5.29

-0.15

Basic EPS - Continuing Operations Growth

-32.33%

+10.09%

-5.97%

-359.83%

+97.16%

Diluted EPS - Continuing Operations

1.93

2.13

2.01

-5.29

-0.15

Diluted EPS - Continuing Operations Growth

-32.04%

+10.36%

-5.63%

-363.18%

+97.16%

Basic Weighted Average Shares Outstanding

509

509

502

504

506

Diluted Weighted Average Shares Outstanding

519

517

508

504

506

Dividend Per Share

0.85

0.96

1.09

1.15

1.16

Dividend Per Share Growth

+16.44%

+12.35%

+13.61%

+5.99%

+0.87%

EBITDA

2,606

2,536

2,597

2,931

2,776

EBITDA Growth

+1.68%

-2.69%

+2.41%

+12.86%

-5.29%

EBITDA Margin %